Biofrontera (BFRI) Accounts Payables (2020 - 2026)
Biofrontera (BFRI) posted quarterly Accounts Payables of $4.8 million for Q4 2025, up 159.21% year-over-year from $1.9 million in Q4 2024, and up 134.23% quarter-over-quarter from $2.1 million in Q3 2025.
Biofrontera (BFRI) Accounts Payables (2020 - 2026) Analysis & Trends
Biofrontera's Accounts Payables history runs 6 years deep, the most recent figure standing at $4.8 million for Q4 2025.
- In Q4 2025, Accounts Payables rose 159.21% year-over-year to $4.8 million; the TTM figure through Dec 2025 stood at $4.8 million (up 159.21% YoY), while the FY2025 annual figure was $4.8 million, up 159.21% from the prior year.
- Accounts Payables for Q4 2025 stood at $4.8 million, up from $2.1 million in the prior quarter.
- The five-year high for Accounts Payables was $4.8 million in Q4 2025, with the low at $100000.0 in Q1 2024.
- The 5-year median for Accounts Payables is $931000.0 (2022), against an average of $1.5 million.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables sank 88.73% in 2024, then jumped 4168.0% in 2025.
- Biofrontera's Accounts Payables stood at $658000.0 in 2021, then jumped by 99.39% to $1.3 million in 2022, then surged by 152.13% to $3.3 million in 2023, then sank by 43.89% to $1.9 million in 2024, then jumped by 159.21% to $4.8 million in 2025.
- Business Quant data shows BFRI's Accounts Payables at $4.8 million in Q4 2025, $2.1 million in Q3 2025, and $4.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | 4.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.32 Mn |
| Dec 31, 2025 | 4.81 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 4.27 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 3.31 Mn |
| Sep 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 887,000.00 |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 253,000.00 |
| Jun 30, 2022 | 931,000.00 |
| Mar 31, 2022 | 302,000.00 |
| Dec 31, 2021 | 658,000.00 |
| Sep 30, 2021 | 367,000.00 |
| Dec 31, 2020 | 176,000.00 |